Research and development
The literature

This section provides a list of some peer-reviewed publications related to chlamydia screening in the UK. The papers are ordered by publication date (most recent first). Click on hyperlink to view PubMed abstract (where available).

2012

Chlamydia screening in England: a qualitative study of the narrative behind the policy.
Sheringham J, Baraitser P, Simms I, Hart G, Raine R. BMC Public Health. 2012 Apr 30;12(1):317. [Epub ahead of print]


Where do young men want to access STI screening? A stratified random probability sample survey of young men in Great Britain.
Saunders JM, Mercer CH, Sutcliffe LJ, Hart GJ, Cassell J, Estcourt CS. Sex Transm Infect. 2012 Apr 17. [Epub ahead of print]


Should young people be paid for getting tested? A national comparative study to evaluate patient financial incentives for chlamydia screening.
Zenner D, Molinar D, Nichols T, Riha J, Macintosh M, Nardone A. BMC Public Health. 2012 Apr 2;12(1):261. [Epub ahead of print]


Can we improve partner notification rates through expedited partner therapy in the UK? Findings from an exploratory trial of Accelerated Partner Therapy (APT).
Estcourt C, Sutcliffe L, Cassell J, Mercer CH, Copas A, James L, Low N, Horner P, Clarke M, Symonds M, Roberts T, Tsourapas A, Johnson AM. Sex Transm Infect. 2012 Feb;88(1):21-6. Epub 2011 Jul 27.


Evaluation of a systematic postal screening and treatment service for genital Chlamydia trachomatis, with remote clinic access via the internet: a cross-sectional study, East of England.
Bracebridge S, Bachmann MO, Ramkhelawon K, Woolnough A. Sex Transm Infect. 2012 Feb 28. [Epub ahead of print]


The cost and cost-effectiveness of opportunistic screening for Chlamydia trachomatis in Ireland.
Gillespie P, O'Neill C, Adams E, Turner K, O'Donovan D, Brugha R, Vaughan D, O'Connell E, Cormican M, Balfe M, Coleman C, Fitzgerald M, Fleming C. Sex Transm Infect. 2012 Jan 2. [Epub ahead of print]


2011

Chlamydia trachomatis screening in young women.
Baraitser P, Alexander S, Sheringham J.
Curr Opin Obstet Gynecol. 2011 Oct;23(5):315-20.


Chlamydia infection, pelvic inflammatory disease, ectopic pregnancy and infertility: cross-national study.
Bender N, Herrmann B, Andersen B, Hocking JS, van Bergen J, Morgan J, van den Broek IV, Zwahlen M, Low N.
Sex Transm Infect. 2011 Oct 25. [Epub ahead of print]


Is Accelerated Partner Therapy (APT) a cost-effective alternative to routine patient referral partner notification in the UK? Preliminary cost-consequence analysis of an exploratory trial.
Roberts TE, Tsourapas A, Sutcliffe L, Cassell J, Estcourt C.
Sex Transm Infect. 2011 Sep 26. [Epub ahead of print]


Will chlamydia screening reach young people in deprived areas in England? Baseline analysis of the English National Chlamydia Screening Programme delivery in 2008.
Sheringham J, Simms I, Riha J, Talebi A, Emmett L, Macintosh M, Raine R.
Sex Transm Dis. 2011 Aug;38(8):677-84.


Who is being tested by the English National Chlamydia Screening Programme? A comparison with national probability survey data.
Riha J, Mercer CH, Soldan K, French CE, Macintosh M.
Sex Transm Infect. 2011 Jun;87(4):306-11. Epub 2011 Mar 22.


Estimation of the rate of pelvic inflammatory disease diagnoses: trends in England, 2000-2008.
French CE, Hughes G, Nicholson A, Yung M, Ross JD, Williams T, Soldan K.
Sex Transm Dis. 2011 Mar;38(3):158-62.


Surveillance of community genital Chlamydia trachomatis testing in the East of England, 2008-2010.
Jennison C, Roddick I, Deas A, Emmett L, Bracebridge S.
J Public Health (Oxf). 2011 Jan 20. [Epub ahead of print]


Costs and cost effectiveness of different strategies for chlamydia screening and partner notification: an economic and mathematical modelling study.
Turner K, Adams E, Grant A, Macleod J, Bell G, Clarke J, Horner P.
BMJ. 2011 Jan 4;342:c7250.


2010

National audit of asymptomatic screening in UK genitourinary medicine clinics: case-notes audit.
McClean H, Carne CA, Sullivan AK, Menon-Johansson A, Gokhale R, Sethi G, Mammen-Tobin AG, Daniels D; National Audit Group of the British Association for Sexual Health and HIV.
Int J STD AIDS. 2010 Jul;21(7):506-11.


Chlamydia trachomatis Genital Infection: Natural History, Immunobiology, and Implications for Control Programs
J Infect Dis. 2010 Jun 15;201 Suppl 2


Chlamydia trachomatis Genital Infection: Natural History, Immunobiology, and Implications for Control Programs
J Infect Dis. 2010 Jun 15;201 Suppl 2


Systematic review of the clinical effectiveness and cost-effectiveness of rapid point-of-care tests for the detection of genital chlamydia infection in women and men.
Hislop J, Quayyum Z, Flett G, Boachie C, Fraser C, Mowatt G. Health Technol Assess. 2010 Jun;14(29):1-97, iii-iv.


The implementation of chlamydia screening: a cross-sectional study in the south east of England.
Johnson SA, Simms I, Sheringham J, Bickler G, Bennett CM, Hall R, Cassell JA.
Sex Transm Infect. 2010 Jun;86(3):217-21. Epub 2010 May 10.


Randomised controlled trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial.
Oakeshott P, Kerry S, Aghaizu A, Atherton H, Hay S, Taylor-Robinson D, Simms I, Hay P.
BMJ. 2010 Apr 8;340:c1642.


Screening and treatment of Chlamydia trachomatis infections.
Kalwij S, Macintosh M, Baraitser P.
BMJ. 2010 Apr 21;340:c1915.


Screening for asymptomatic chlamydia in women: How often would gonorrhoea be missed?
Mahto M, Lavelle SJ, Mallinson H. Int J STD AIDS. 2010 Feb;21(2):149-50.



2009

Epidemiology of Chlamydia trachomatis infection in women and the cost-effectiveness of screening.
Land JA, Van Bergen JE, Morré SA, Postma MJ.
Hum Reprod Update. 2009 Oct 14. [Epub ahead of print]


Promoting chlamydia screening with posters and leaflets in general practice--a qualitative study.
Freeman E, Howell-Jones R, Oliver I, Randall S, Ford-Young W, Beckwith P, McNulty C.
BMC Public Health. 2009 Oct 12;9:383


The English National Chlamydia Screening Programme: variations in positivity in 2007/2008.
Simms I, Talebi A, Rhia J, Horner P, French RS, Sarah R, Macintosh M.
Sex Transm Dis. 2009 Aug;36(8):522-7.


A qualitative study of pharmacists' views on offering chlamydia screening to women requesting emergency hormonal contraception.
Thomas G, Humphris G, Ozakinci G, O'Brien K, Roberts SA, Hopkins M, Brabin L.
BJOG. 2009 Sep 23.


Screening for asymptomatic chlamydia in women - how often would gonorrhoea be missed?
Rosenvinge MM, Lau R.
Int J STD AIDS. 2009 Aug;20(8):571-2.


Chlamydia screening programme, HMP Hydebank Wood Young Offender Centre, Belfast, Northern Ireland, UK.
Hirst H, Dinsmore WW.
Int J STD AIDS. 2009 May;20(5):360-1.


Predicting the population impact of chlamydia screening programmes: comparative mathematical modelling study.
Kretzschmar M, Turner KM, Barton PM, Edmunds WJ, Low N.
Sex Transm Infect. 2009 May 18. [Epub ahead of print]


Monitoring inequalities in the National Chlamydia Screening Programme in England: added value of ACORN, a commercial geodemographic classification tool.
Sheringham J, Sowden S, Stafford M, Simms I, Raine R.
Sex Health. 2009 Mar;6(1):57-62.


Delivery of chlamydia screening to young women requesting emergency hormonal contraception at pharmacies in Manchester, UK : a prospective study.
Brabin L, Thomas G, Hopkins M, O'Brien K, Roberts SA.
BMC Womens Health. 2009 Mar 26;9(1):7. [Epub ahead of print]


University undergraduates' knowledge of chlamydia screening services and chlamydia infection following the introduction of a National Chlamydia Screening Programme.
Greaves A, Lonsdale S, Whinney S, Hood E, Mossop H, Olowokure B.
Eur J Contracept Reprod Health Care. 2009 Feb;14(1):61-8.


Willingness of young men and women to be tested for Chlamydia trachomatis in three non-medical settings in Glasgow, UK.
Lorimer K, Reid ME, Hart GJ.
J Fam Plann Reprod Health Care. 2009 Jan;35(1):21-6.


Novel interventions to reduce re-infection in women with chlamydia: a randomized controlled trial.
Cameron ST, Glasier A, Scott G, Young H, Melvin L, Johnstone A, Elton R.
Hum Reprod. 2009 Jan 9. [Epub ahead of print]



2008

It has to speak to people's everyday life…': Qualitative Study of Men and Women's Willingness to Participate in a Non-Medical Approach to Chlamydia trachomatis Screening.
Lorimer K, Reid ME, Hart GJ.
Sex Transm Infect. 2008 Dec 23. [Epub ahead of print]


Opportunistic screening for Chlamydia: a pilot study into male perspectives on provision of Chlamydia screening in a UK university.
Chaudhary R, Heffernan CM, Illsley AL, Jarvie LK, Lattimer C, Nwuba AE, Platford EW.
J Public Health (Oxf). 2008 Dec;30(4):466-71.


Pilot study of young peoples' attitudes to opportunistic Chlamydia testing in UK general practice.
Heritage J, Jones MM.
Reprod Health. 2008 Dec 19;5(1):11. [Epub ahead of print]


Community-based trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial.
Oakeshott P, Kerry S, Atherton H, Aghaizu A, Hay S, Taylor-Robinson D, Simms I, Hay P.
Trials. 2008 Dec 10;9(1):73. [Epub ahead of print]


Effectiveness of chlamydia screening: systematic review.
Low N, Bender N, Nartey L, Shang A, Stephenson JM.
Int J Epidemiol. 2008 Dec 5. [Epub ahead of print]


Integrated community-based sexual health services for young people in urban areas: are we meeting the needs of the local community?
Forbes KM, Rahman N, McCrae S, Reeves I.
Int J STD AIDS. 2008 Oct;19(10):713-4.


Strategies used to increase chlamydia screening in general practice: a qualitative study.
McNulty CA, Freeman E, Oliver I, Ford-Young W, Randall S.
Public Health. 2008 Sep;122(9):845-56.


Interactive workshops increase chlamydia testing in primary care--a controlled study.
McNulty CA, Thomas M, Bowen J, Buckley C, Charlett A, Gelb D, Foy C, Sloss J, Smellie S.
Fam Pract. 2008 Aug;25(4):279-86.


Feasibility of screening for Chlamydia trachomatis in young men attending an emergency department.
Sood T, Sally D, Spencer N, Banerjee A, Hinchley G.
Emerg Med J. 2008 Jul;25(7):428-30.


Pee-in-a-Pot Day: Lincoln College's Chlamydia screening day.
Plunkett, B.
Education and Health, 2008:26 (1) pp. 14-15



2007

Chlamydia testing in community pharmacies: evaluation of a feasibility pilot in south east London.
Baraitser P, Pearce V, Holmes J, Horne N, Boynton PM.
Qual Saf Health Care. 2007 Aug;16(4):303-7.


Incidence and reinfection rates of genital chlamydial infection among women aged 16-24 years attending general practice, family planning and genitourinary medicine clinics in England: a prospective cohort study by the Chlamydia Recall Study Advisory Group.
Scott Lamontagne D, Baster K, Emmett L, Nichols T, Randall S, McLean L, Meredith P, Harindra V, Tobin JM, Underhill GS, Graham Hewitt W, Hopwood J, Gleave T, Ghosh AK, Mallinson H, Davies AR, Hughes G, Fenton KA; Chlamydia Recall Study Advisory Group.
Sex Transm Infect. 2007 Jul;83(4):292-303.


The cost effectiveness of opportunistic chlamydia screening in England.
Adams EJ, Turner KM, Edmunds WJ.
Sex Transm Infect. 2007 Jul;83(4):267-74; discussion 274-5.


Chlamydia Screening: the Role of General Practice.
Emmett L, Battison T, Clarke J.
Trends in Urology, Gynaecology & Sexual Health 2007; May/June:11-14


The National Chlamydia Screening Programme and the NICE guidance on one-to-one interventions: remember the under-25s.
Simms I, Battison T, Macintosh M, Randall S, Clarke J.
Sex Transm Infect. 2007 Apr;83(2):171.


NICE guidance and the National Chlamydia Screening Programme.
Stephenson J.
Sex Transm Infect. 2007 Apr;83(2):170.


Screening programmes for chlamydial infection: when will we ever learn?
Low N.
BMJ. 2007 Apr 7;334(7596):725-8. Review.


Screening for Chlamydia trachomatis.
Jones R, Boag F.
BMJ. 2007 Apr 7;334(7596):703-4.


Epidemiological, social, diagnostic and economic evaluation of population screening for genital chlamydial infection.
Low N, McCarthy A, Macleod J, Salisbury C, Campbell R, Roberts TE, Horner P, Skidmore S, Sterne JA, Sanford E, Ibrahim F, Holloway A, Patel R, Barton PM, Robinson SM, Mills N, Graham A, Herring A, Caul EO, Davey Smith G, Hobbs FD, Ross JD, Egger M; Chlamydia Screening Studies Project Group.
Health Technol Assess. 2007 Mar;11(8):iii-iv, ix-xii, 1-165. Review.


Chlamydia screening in a rural population: access, outcomes and health-care planning.
Bendall RP, Keane FE, Barlow MJ, Paynter SJ.
Int J STD AIDS. 2007 Feb;18(2):89-92.



2006

Modelling the effectiveness of chlamydia screening in England.
Turner KM, Adams EJ, Lamontagne DS, Emmett L, Baster K, Edmunds WJ.
Sex Transm Infect. 2006 Dec;82(6):496-502.


With appropriate incentives, general practice can improve the coverage of the National Chlamydia Screening Programme.
Ma R.
Br J Gen Pract. 2006 Nov;56(532):892-3.


A comparison of the population diagnosed with chlamydia in primary care with that diagnosed in sexual health clinics: implications for a national screening programme.
Cassell JA, Mercer CH, Fenton KA, Copas AJ, Erens B, Wellings K, Johnson AM.
Public Health. 2006 Oct;120(10):984-8.



2005

Partner notification of chlamydia infection in primary care: randomised controlled trial and analysis of resource use.
Low N, McCarthy A, Roberts TE, Huengsberg M, Sanford E, Sterne JA, Macleod J, Salisbury C, Pye K, Holloway A, Morcom A, Patel R, Robinson SM, Horner P, Barton PM, Egger M.
BMJ. 2006 Jan 7;332(7532):14-9. Epub 2005 Dec 15.


Chlamydia screening in general practice: views of professionals on the key elements of a successful programme.
Ma R, Clarke A.
J Fam Plann Reprod Health Care. 2005 Oct;31(4):302-6.


Implementation of chlamydia screening in a general practice setting: a 6-month pilot study.
Harris DI.
J Fam Plann Reprod Health Care. 2005 Apr;31(2):109-12.


Using chlamydia positivity to estimate prevalence: evidence from the Chlamydia Screening Pilot in England.
LaMontagne DS, Fenton KA, Pimenta JM, Catchpole M, Rogers PA, Randall S, Hewitt WG, Mallinson H, Underhill GS, McLean L, Gleave T, Harindra V, Ghosh AK, Tobin JM.
Int J STD AIDS. 2005 Apr;16(4):323-7.


Screening for chlamydia: seize the day.
Randall S, LaMontagne DS.
J Fam Plann Reprod Health Care. 2005 Apr;31(2):98-100.


Screening for chlamydial infection: are we doing enough?
Miller WC.
Lancet. 2005 Feb 5-11;365(9458):456-8.


Screening for chlamydia.
Macleod J, Salisbury C, Low N.
Lancet. 2005 Apr 30-May 6;365(9470):1539-40.



2004

Modelling the healthcare costs of an opportunistic chlamydia screening programme.
Adams EJ, LaMontagne DS, Johnston AR, Pimenta JM, Fenton KA, Edmunds WJ.
Sex Transm Infect. 2004 Oct;80(5):363-70.


Re-infection of Chlamydia trachomatis in patients presenting to the genitourinary medicine clinic in Portsmouth: the chlamydia screening pilot study - three years on.
Lee VF, Tobin JM, Harindra V.
Int J STD AIDS. 2004 Nov;15(11):744-6.


The chlamydia screening studies: rationale and design.
Low N, McCarthy A, Macleod J, Salisbury C, Horner PJ, Roberts TE, Campbell R, Herring A, Skidmore S, Sanford E, Sterne JA, Davey Smith G, Graham A, Huengsberg M, Ross J, Egger M.
Sex Transm Infect. 2004 Oct;80(5):342-8.


Establishing the National Chlamydia Screening Programme in England: results from the first full year of screening.
LaMontagne DS, Fenton KA, Randall S, Anderson S, Carter P.
Sex Transm Infect. 2004 Oct;80(5):335-41.


National chlamydia screening programme in England: making progress.
Fenton KA, Ward H.
Sex Transm Infect. 2004 Oct;80(5):331-3.


Barriers to opportunistic chlamydia testing in primary care.
McNulty CA, Freeman E, Bowen J, Shefras J, Fenton KA.
Br J Gen Pract. 2004 Jul;54(504):508-14.


National screening programme for chlamydia exists in England.
Fenton KA, LaMontagne DS, Randall S.
BMJ. 2004 Jul 17;329(7458):172.


Diagnosis of genital chlamydia in primary care: an explanation of reasons for variation in chlamydia testing.
McNulty CA, Freeman E, Bowen J, Shefras J, Fenton KA.
Sex Transm Infect. 2004 Jun;80(3):207-11.



2003

Opportunistic screening for Chlamydia in general practice: the experience of health professionals.
Perkins E, Carlisle C, Jackson N.
Health Soc Care Community. 2003 Jul;11(4):314-20.


Opportunistic screening for genital chlamydial infection. II: prevalence among healthcare attenders, outcome, and evaluation of positive cases.
Pimenta JM, Catchpole M, Rogers PA, Hopwood J, Randall S, Mallinson H, Perkins E, Jackson N, Carlisle C, Hewitt G, Underhill G, Gleave T, McLean L, Ghosh A, Tobin J, Harindra V.
Sex Transm Infect. 2003 Feb;79(1):22-7. Erratum in: Sex Transm Infect. 2004 Apr;80(2):156.


Opportunistic screening for genital chlamydial infection. I: acceptability of urine testing in primary and secondary healthcare settings.
Pimenta JM, Catchpole M, Rogers PA, Perkins E, Jackson N, Carlisle C, Randall S, Hopwood J, Hewitt G, Underhill G, Mallinson H, McLean L, Gleave T, Tobin J, Harindra V, Ghosh A.
Sex Transm Infect. 2003 Feb;79(1):16-21.


Chlamydia screening in the United Kingdom.
Catchpole M, Robinson A, Temple A.
Sex Transm Infect. 2003 Feb;79(1):3-4.  (Editorial)



Be proactive
The National Chlamydia Screening Programme (NCSP) is a control and prevention programme targeted at the highest risk group for chlamydia infection in England, young people under 25 who are sexually active.

Chlamydia is often asymptomatic so a large proportion of cases remain undiagnosed, but infection can be diagnosed easily (young people can do the test themselves), and treated effectively.

To find your local Chlamydia Screening Office or to register with us enter your post code or select your region on the map

uk map North West North East Yorkshire and Humber East Midlands West Midlands East of England South West South Central London South East
Please enter full postcode: